Navigation Links
NxStage Reports Sustained Reduction in Clinical Depressive Symptoms for Daily Home Hemodialysis Patients After One Year
Date:3/9/2009

>

  • A nearly 50 percent improvement in mean BDI scores occurred for patients with moderate to severe depressive symptoms.

  • Baseline BDI scores did not significantly differ amongst patients who did not complete 12 month follow-up compared to those who did, indicating that there was no biased selection in the compilation of data.

Dr. Frederic Finkelstein, MD, Chief of Nephrology at the Hospital of St. Raphael in New Haven, Conn. and Clinical Professor of Medicine at Yale University Medical School as well as an investigator on the FREEDOM study, presents the 12-month BDI data today during the 29th Annual Dialysis Conference in Houston.

"Depression is a serious, often undiagnosed problem for ESRD patients. The 12-month study results are extremely encouraging because they indicate that for eligible patients, switching to daily home hemodialysis may provide lasting relief of depression symptoms, especially for patients in greatest need -- those with moderate to severe depression," says Dr. Finkelstein. "In turn, addressing the problem of depression in patients could translate into less hospitalizations and improved morbidity and mortality, helping to alleviate the physical and emotional burden on patients and their families, as well as the financial burden on the healthcare system."

"We are pleased to see FREEDOM's latest interim results show how daily home therapy with the NxStage System One can lessen the impact of depressive symptoms on patients with ESRD," says Jeff Burbank, CEO of NxStage Medical, Inc. "FREEDOM continues to reaffirm our mission to bring long-term health and quality of life benefits to more patients, and we look forward to sharing further interim results from FREEDOM as other milestones are reached."

The 12-month BDI results come out of the ongoing FREEDO
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. iSirona Signs Reference Selling Agreement with NxStage
2. NxStage to Report Fourth Quarter and Full Year 2008 Financial Results
3. First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary
4. NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloittes 2008 Technology Fast 500
5. NxStage Applauds Array of Studies To Be Presented at American Society of Nephrology Meeting
6. NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy
7. NxStage Reports Third Quarter 2008 Financial Results
8. NxStage Appoints New Member to Its Board of Directors and Announces Resignation of Board Member
9. NxStage Announces Presentation of Data at the American Society of Nephrologys Renal Week 2008 Annual Meeting
10. NxStage Reports Second Quarter 2008 Financial Results
11. NxStage Announces $43 Million Private Placement of Equity Securities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... testosterone falls below normal levels are more likely to ... heart disease and type 2 diabetes. A new simple ... testing and possible treatment is described in an article ... publication from Mary Ann Liebert, Inc., publishers. The article ... Health website at http://www.liebertpub.com/jmh . ...
(Date:4/23/2014)... science, "simple and accessible detection methods that can ... resolution of a single cell inside that population ... engineer Chang Lu. , In the Royal Society ... has announced that he and his coworkers have ... location of a protein ( Chem. Sci. , ...
(Date:4/23/2014)... of probiotics, antioxidants and other nutritional compounds, more and ... is getting in on the action. But legitimate skepticism ... industry is responding with clinical research to shore up ... Chemical & Engineering News (C&EN), the weekly news ... Bomgardner, a senior editor at C&EN, writes that about ...
(Date:4/23/2014)... country as wealthy as the United States, it may come ... have access to adequate food due to lack of money ... Recent research at the University of Illinois using data from ... the seniors who are dealing with hunger are also facing ... percent of Americans over age 60 faced the threat of ...
(Date:4/23/2014)... a researcher from the Cancer Science Institute of Singapore ... identified the cancer specific stem cell which causes gastric ... new drugs for the treatment of this disease and ... by Dr Chan Shing Leng, Research Assistant Professor at ... cancer-specific variant of a cell surface protein, CD44v8-10, marks ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3
... ... to electronic medical records for attendees of the Michigan Osteopathic Association’s (MOA) 111th Annual ... ... Secure-24 and ATMP offered leadership and guidance about the transition from paper to electronic ...
... ... recently appointed industry leader Steve Potts as CEO. Dr. Potts brings strong business experience ... ... Biosciences LLC, a provider of digital pathology services, announced that Steven Potts ...
... 24, 2010 Genetic variation due to DNA mutation ... well as a contributing factor to disease. However, ... understood. In a report published online today in ... identified intrinsic properties of DNA that influence mutation rate, ...
... restricts the supply of blood to tumours has been developed ... vaccine slows the growth of breast cancer tumours in mice. ... a few millimetres it must be able to stimulate the ... supply of oxygen and nutrients. Drugs that prevent the growth ...
... lagging behind other developed countries, study finds , MONDAY, ... children under the age of 5 appears to be ... deaths -- than the latest mortality estimates released by ... number-crunching conducted by researchers at the Institute for Health ...
... , ... Company offers affordable expert facilitation, project management support and peer-to-peer learning opportunities to ... ... the American Academy of Family Physicians, today announced a new service offering aimed ...
Cached Medicine News:Health News:ATMP and Secure-24 Offer Physicians Leadership and Guidance for Electronic Medical Records 2Health News:ATMP and Secure-24 Offer Physicians Leadership and Guidance for Electronic Medical Records 3Health News:Digital Pathology Services Firm Flagship Biosciences Appoints New CEO 2Health News:Digital Pathology Services Firm Flagship Biosciences Appoints New CEO 3Health News:New research indicates that DNA sequence itself influences mutation rate 2Health News: A new cancer vaccine starves tumors of blood 2Health News:Global Death Rate for Children Lower Than Thought 2Health News:TransforMED Launches New Service Offering to Accelerate Medical Home Adoption in Small Practices 2Health News:TransforMED Launches New Service Offering to Accelerate Medical Home Adoption in Small Practices 3Health News:TransforMED Launches New Service Offering to Accelerate Medical Home Adoption in Small Practices 4
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
(Date:1/15/2014)... 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... patent application concerning composition of matter, biological targets, mechanism ... cell death.  This patent application describes ... RNA molecules (VSRNAs) which interfere with the basic homeostatic ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... N.J., Nov. 3 , Third-Quarter 2009 Highlights: , ... $0.58 in third-quarter 2008 Record diluted EPS, excluding $0.06 ... $0.75, up 19.0 percent from $0.63 in third-quarter 2008 ... Specialty pharmacy revenues increased 19.2 percent to a record of ...
... , MOUNTAIN VIEW, Calif., Nov. 3 VIVUS, ... promotion of Peter Tam to president of VIVUS. In ... responsibility for VIVUS, development and business functions, including corporate ... regulatory affairs and chemistry, manufacturing and controls. Leland Wilson, ...
Cached Medicine Technology:Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 2Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 3Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 4Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 5Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 6Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 7Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 8Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 9Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 10Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 11Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 12Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 13Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 14Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 15Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 16Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 17Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 18Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 19Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 20Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 21Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 22Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 23Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 24Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 25Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 26Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 27Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 28Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75 29VIVUS Announces Promotion of Peter Tam to President 2VIVUS Announces Promotion of Peter Tam to President 3
... better. How can one of the leading ... becoming more convenient to use in all ... TwinFix Suture Anchor with Needles combines the ... and timesaving anchor inserter and needle delivery ...
... The TACIT Threaded Anchor ... used in craniofacial and ... easy, secure tissue reattachment ... suspension. The small size ...
The Mini Anchor is an exceptionally strong, versatile anchor. This anchor comes in either a load-your-own or QUICKANCHOR format, preloaded on either 2/0 or 0 ETHIBOND EXCEL suture with swaged needles...
... FASTIN RC is a ... for rotator cuff procedures. The ... a small core to optimize ... independent suture channels to prevent ...
Medicine Products: